Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.225 -3.86% 5.60 78,897 16:35:14
Bid Price Offer Price High Price Low Price Open Price
5.55 6.00 5.55 5.55 5.55
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 4.66 -0.04 0.05 112.0 17
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:14 UT 343 5.60 GBX

Proteome Sciences (PRM) Latest News

More Proteome Sciences News
Proteome Sciences Investors    Proteome Sciences Takeover Rumours

Proteome Sciences (PRM) Discussions and Chat

Proteome Sciences Forums and Chat

Date Time Title Posts
30/7/202120:01Proteome Sciences leading Alzheimer's technology.89,860
27/7/202100:30Proteome, what next? (moderated)59,142
13/5/202019:36Only worth 3p on fundamentals....10
28/4/202007:22Proteome Sciences plc, A Three Horse Race for the Month of May.4,854
02/7/201917:54The useful PRM thread13

Add a New Thread

Proteome Sciences (PRM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Proteome Sciences trades in real-time

Proteome Sciences (PRM) Top Chat Posts

Proteome Sciences Daily Update: Proteome Sciences Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker PRM. The last closing price for Proteome Sciences was 5.83p.
Proteome Sciences Plc has a 4 week average price of 5.50p and a 12 week average price of 5.50p.
The 1 year high share price is 9.95p while the 1 year low share price is currently 3.02p.
There are currently 294,648,723 shares in issue and the average daily traded volume is 328,338 shares. The market capitalisation of Proteome Sciences Plc is £16,500,328.49.
stocktastic: Peverill - that and awarding herself a load of low price options that pay out even if the share price totally collapses from a lack of performance Is there even a corporste presentation uploaded? I expect she will announce news... of a fundraiser to do some deal. Maybe with the deal news, maybe just for the promise of a deal. The deal being to buy some small asset or small loss making company. Alternative is sell TMT to get cash for a deal, but would leave PRM with negative cash flow again. What else can they do?
wellhonedhutch: I understand your thinking stocktastic but if (if) stroke is likely to get it's C E mark soon, and it is expected as I understand it to be .....why would PRM not wait for this to transpire, then raise capital with a much higher price and especially as PRM income streams seem to put the company on a modest but forward looking profit trajectory?
stocktastic: "Well obviously our expectation is we will see a good development upwards, which will be triggered by all the activities we will be taking, particularly on the strategic side ........ this year, ........ and should definitely positively influence the share price"" I find this hard to believe If they managed to get some big new deal for TMT or services,fine However, I suspect strategic plans are about buying something. Issuing a boatload of stock to buy an asset that is making little, or no money yet,doesnt tend to excite the share price Nearly 1 year in and I'm not aware of anything the CEO has done beyond cost money and issue directors cheap options. Doesnt mean she hasnt done more,of course. ...I dont expect much 'strategic uplift',but well, surprise me Mariola
wasjobber: You all need to remember what the new CEO said about the share price during the recent company webinar :- "Well obviously our expectation is we will see a good development upwards, which will be triggered by all the activities we will be taking, particularly on the strategic side ........ this year, ........ and should definitely positively influence the share price" HTTPS:// She couldn't be any clearer! I personally think the strategic moves will be triggered by the release of the new clinical Stroke tests. Of course, it could revolve around any one of the many other IP assets PRM owns.
tom barnaby: Dont remind us goatherd. This was 13 years ago to the day! Peter Snodgrass 27 May '08 - 08:32 - 33114 of 59071 0 0 0 The implications of post 33070, and the subsequent discussions, appear IMO/DYOR to suggest that: a. A takeover bid from ABI is likely in the near future, possibly this week. b. The EVO policy now seems to put a floor under the price of around 40p. c. Anyone buying at around the present price level seems likely to gain a profit of at least around a doubling of the share price in the relatively near future. d. A takeover auction for PRM at a multiple of the present price seems likely in due course. e. Anyone selling at this price seems likely (probably even in the near future) greatly to regret it. Regards, Peter.
elpirata: Peter Snodgrass - 2 Jan'08 - some "sensible posters" are too dim to understand the blindingly obvious.....shortly get proof of my theory via GE taking Intronn (either in cash or in part exchange) and handing back to PRM most of the rest of PRM's IP....will result, probably quite soon, in the true value (well over £8 - probably £12 - per share) of PRM becoming apparent - resulting in a takeover auction for PRM which I expect GE to win.
pxpx: Interesting read on here over the last few days and nice to see a "relative" improvement in the share price I was genuinely sorry to read Canalletto's post and I'm sure there are many similar saddening stories for longer term PRM "investors". I was living in the UK 20 years ago and also believed the hype and invested heavily into PRM (and OXB). I can't recall the exact details but most of my purchases were in the "glory" days of 2 pounds.... Suffice to say, my investment in both stocks hasn't turned out so well. Luckily for me, I was only in my 20's at the time and although it was a lot of money for me at the time (>20k pounds in PRM), I can now safely put the whole exercise down to an expensive life lesson. I still own all of the shares that I purchased, but even with the recent share price improvements, it's still worth <10% of my original investment. And on the upside, my OXB purchases still have a chance of turning a profit! :-)
small crow: Helium perhaps selling another half-million today then? Is that why their mates are maintaining this price in spite of news vacuum? Throughout 99% of history the PRM share price has slumped without news. I love increases but prefer them to be based on real progress rather than financial 'engineering' as it is sometimes called by those who do simple arithmetic on coins.
stocktastic: Now it just needs Mariola to do a fundraiser / issuance for her strategic plans and the share price can go back down ... although a cash generating PRM could potentially find a nice bolt-on Ie..not yet profitable company to strip costs out from... or a complementary asset. Challenge though,is that PRM only sells its TMT based biomarker services. There are many alternative services that could fit, but how many that would add value or synergy, I dont know. Some other labelling or cell analysis tech.maybe. PRM could find another approach that only it could offer?
bluemango: Excuse me, I seem to have inadvertently stepped into a time machine back to 2003 (apart from the PRM share price which remains stubbornly low). There must be a door somewhere in this thing, hang on.
Proteome Sciences share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Proteome S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210731 18:34:04